Cited by 156Schizophrenia research and treatmentSuicide and Self-Harm StudiesMental Health Treatment and Access

Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort

Open access
Reininghaus, Ulrich, Dutta, Rina, Dazzan, Paola, Doody, Gillian A., Fearon, Paul, Lappin, Julia, Heslin, Margaret, Onyejiaka, Adanna +7 more·2015·Schizophrenia Bulletin

Abstract

The excess mortality in people with psychotic disorders is a major public health concern, but little is known about the clinical and social risk factors which may predict this health inequality and help inform preventative strategies. We aimed to investigate mortality in a large epidemiologically characterized cohort of individuals with first-episode psychosis compared with the general population and to determine clinical and social risk factors for premature death. All 557 individuals with first-episode psychosis initially identified in 2 areas (Southeast London and Nottinghamshire, United Kingdom) were traced over a 10-year period in the ӔSOP-10 study. Compared with the general population, all-cause (standardized mortality ratio [SMR] 3.6, 95% confidence interval [CI] 2.6-4.9), natural-cause (SMR 1.7, 95% CI 1.0-2.7) and unnatural-cause (SMR 13.3, 95% CI 8.7-20.4) mortality was very high. Illicit drug use was associated with an increased risk of all-cause mortality (adj. rate ratio [RR] 2.31, 95% CI 1.06-5.03). Risk of natural-cause mortality increased with a longer time to first remission (adj. RR 6.61, 95% CI 1.33-32.77). Family involvement at first contact strongly reduced risk of unnatural-cause mortality (adj. RR 0.09, 95% CI 0.01-0.69). Our findings suggest that the mortality gap in people with psychotic disorders remains huge and may be wider for unnatural-cause mortality than previously reported. Efforts should now focus on further understanding and targeting these tractable clinical and social risk factors of excess mortality. Early intervention and dual diagnosis services may play a key role in achieving more rapid remission and carer involvement and addressing substance use problems to reduce excess mortality in psychosis.

AI snapshot

Written from the paper’s full text.

TL;DR

In a 10-year follow-up of 549 first-episode psychosis cases from the ӔSOP cohort, all-cause mortality was 3.6 times higher than in the local general population, with especially marked excess unnatural-cause and suicide mortality. Illicit drug use, longer time to first remission, and lack of family involvement at first contact were linked to higher mortality risk.

Key findings

  • Of 549 cases, 39 (7.1%; 717.3 per 100 000 person-years) died: 15 from natural causes, 21 from unnatural causes, and 3 from unknown causes.
  • Compared with the local general population, SMRs were 3.6 (95% CI 2.6–4.9) for all-cause mortality, 1.7 (95% CI 1.0–2.7) for natural-cause mortality, 13.3 (95% CI 8.7–20.4) for unnatural-cause mortality, and 20.0 (95% CI 11.7–34.5) for suicide.
  • Illicit drug use was associated with increased all-cause mortality (adj. RR 2.31, 95% CI 1.06–5.03) and unnatural-cause mortality (adj. RR 3.78, 95% CI 1.11–12.89 in the adjusted model; text notes attenuation to adj. RR 3.25, 95% CI 0.96–11.03 after confounding by family involvement).
  • Longer time to first remission (>2 years) increased natural-cause mortality risk (adj. RR 6.61, 95% CI 1.33–32.77), while full family involvement at first contact strongly reduced unnatural-cause mortality risk (adj. RR 0.09, 95% CI 0.01–0.69).

Methods

  • ӔSOP-10 traced 557 individuals with first-episode psychosis initially identified in Southeast London and Nottinghamshire over a mean 10.0 years (SD = 2.3); after exclusions, 549 were analyzed.
  • Deaths and emigration were identified via the Office for National Statistics and General Register Office; underlying causes were classified from ICD-10 death certificates into natural, unnatural, and unknown causes, with clinical-record information from an extended WHO Life Chart.
  • Analyses included crude mortality rates, Kaplan–Meier plots, Cox regression, Poisson regression for risk factors, and indirect standardization to calculate SMRs against local general-population rates by age band, sex, and study center.

Limitations

  • The paper states that baseline clinical and social factors may have varied over time, mortality was statistically rare leading to wide CIs and imprecise estimates, and unmeasured confounding by smoking, obesity, lifestyle, medication, and healthcare access/quality cannot be ruled out; alcohol use at baseline was not measured as a risk factor.
  • The paper also notes that findings may not be directly comparable with studies of more severe and enduring psychosis rather than first-episode cohorts.
  • Evident from the text: the observational design cannot establish causality, and several covariates had missing data (e.g., DUP n = 41, time to first remission n = 123, illicit drug use n = 88, family involvement n = 64), which may affect precision or bias.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/schbul/sbu138

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 60 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    Among natural-cause deaths, 3 (0.6%, 55.2 per 100 000 person-years) were probable alcohol-related.

    “and 3 (0.6%, 55.2 per 100 000 person-years) from probable alcohol-related causes”
    Quote in the paperNot a substantial claim
  • Findingown data

    All-cause SMRs were of similar magnitude in London and Nottingham.

    “All-cause SMRs were of similar magnitude in the 2 study sites (London and Nottingham)”
    Quote in the paperNot a substantial claim
  • Findingown data

    Mortality rates for all causes, natural causes, and unnatural causes of death were similar in London and Nottingham.

    “Mortality rates for all causes, natural causes, and unnatural causes of death were similar in London and Nottingham.”
    Quote in the paperNot a substantial claim
  • Findingown data

    Long time to first remission was associated with a shorter time to all- and natural-cause death in Kaplan-Meier survival curves.

    “There was evidence from Kaplan–Meier survival curves that a long DUP (see supplementary figure 3) and a long time to first remission (see supplementary figure 4) were associated with a shorter time to all- and natural-cause death.”
    Quote in the paperSubstantial claim
  • Findingown data

    Of the 549 cases, 21 (3.8%, 386.3 per 100 000 person-years) died due to unnatural causes.

    “21 (3.8%, 386.3 per 100 000 person-years) due to unnatural causes”
    Quote in the paperSubstantial claim
  • May combine two claims. 12
  • The quote only partly states this claim. 2
  • Classified as probably not a substantial claim. 11
  • May combine two claims.

    Findingown data

    While a long DUP was associated with an increased risk of all- and natural-cause mortality in unadjusted analyses, this association was attenuated and ceased to be statistically significant when adjusting for age at baseline and sex.

    “While a long DUP was associated with an increased risk of all- and natural-cause mortality in unadjusted analyses, this association was attenuated and ceased to be statistically significant when adjusting for age at baseline and sex.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Natural-cause SMRs were equally elevated in London and Nottingham as well as in men and women, but not statistically significant at conventional levels.

    “Natural-cause SMRs were equally elevated in London and Nottingham as well as in men and women, but not statistically significant at conventional levels (ie, P < .05).”
    Quote in the paperNot a substantial claim
  • The quote only partly states this claim.

    Findingown data

    Younger cases (16-29 years) had lower natural-cause mortality rate (265.6 per 100 000 person-years) than older cases (30-65 years).

    “Younger cases had lower mortality rates for all causes (466.3 per 100 000 person-years) and natural causes (265.6 per 100 000 person-years).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Mortality rates for all causes, natural causes, and unnatural causes of death were slightly lower in cases from a Black and Minority Ethnic (BME) group than in white British cases, but CIs were wide.

    “Mortality rates for all causes, natural causes, and unnatural causes of death were slightly lower in cases from a Black and Minority Ethnic (BME) group than in white British cases, but CIs for these point estimates were wide.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    There was some limited variation in mortality rates by time since first presentation to services, but overall these were broadly similar over the follow-up period.

    “While there was some limited variation in mortality rates by time since first presentation to services, overall, these were broadly similar over the follow-up period”
    Quote in the paperNot a substantial claim
  • The quote only partly states this claim.

    Findingown data

    Younger cases (16-29 years) had lower all-cause mortality rate (466.3 per 100 000 person-years) than older cases (30-65 years).

    “Younger cases had lower mortality rates for all causes (466.3 per 100 000 person-years) and natural causes (265.6 per 100 000 person-years).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    There was no strong evidence that unnatural-cause SMRs varied by place, sex, or age and these SMRs remained high for older cases (aged 60-74 years).

    “There was no strong evidence that unnatural-cause SMRs varied by place, sex, or age and these SMRs remained high for older cases (ie, aged 60–74 years).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    There was some weak evidence that the increase in natural-cause mortality was higher in age bands 30-44 years and 45-59 years than in age bands 16-29 years and 60-74 years; however, CIs were wide and overlapped across age bands.

    “There was some weak evidence that the increase in natural-cause mortality was higher in age bands 30–44 years and 45–59 years than in age bands 16–29 years and 60–74 years; however, CIs were wide and overlapped across age bands.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    There was some evidence of a more marked excess of suicide in London than in Nottingham.

    “with some evidence of there being a more marked excess of suicide in London than in Nottingham.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductcitation

    Underlying cause of death was further ascertained based on extensive information collated from clinical records at follow-up using an extended version of the WHO Life Chart.

    “The underlying cause of death recorded on copies of death certificates was further ascertained based on extensive information collated from clinical records at follow-up using an extended version of the World Health Organization (WHO) Life Chart.28,30”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [28] 2014, Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study, Psychol Med source

      Not checked in the free run.

    • cites [30] 1996, Long-term follow-up of schizophrenia in 16 countries. A description of the International Study of Schizophrenia conducted by the World Health Organization, Soc Psychiatry Psychiatr Epidemiol source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Conflicting results have been recently reported as to whether illicit drug use contributes to excess mortality in psychosis.

    “Conflicting results have been recently reported as to whether illicit drug use contributes to excess mortality in psychosis.2,25,26”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [2] 2013, Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study, Am J Psychiatry source

      Not checked in the free run.

    • cites [25] Oregon Department of Human Services, 2008

      Not checked in the free run.

    • cites [26] 2011, The impact of substance use disorders on the course of schizophrenia—a 15-year follow-up study: dual diagnosis over 15 years, Schizophr Res source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    The mortality gap in people with psychotic disorders remains huge and may be wider for unnatural-cause mortality than previously reported.

    “Our findings suggest that the mortality gap in people with psychotic disorders remains huge and may be wider for unnatural-cause mortality than previously reported.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductcitation

    Principal underlying causes of death were determined according to ICD-10 as recorded on death certificates obtained from ONS.

    “For all identified deaths, principal underlying causes of death were determined according to the International Classification of Diseases, 10th revision (ICD-10),29 as recorded on copies of death certificates obtained from ONS.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [29] World Health Organization, 1992

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Premisecitation

    Evidence as to whether excess mortality in psychotic disorders is predominantly due to unnatural or natural causes remains equivocal.

    “Evidence as to whether excess mortality is predominantly due to unnatural or natural causes of death remains equivocal.2,7,9,12”
    Quote in the paperSubstantial claim0 of 4 sources checked
    • cites [2] 2013, Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study, Am J Psychiatry source

      Not checked in the free run.

    • cites [7] 2012, Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia, Gen Hosp Psychiatry source

      Not checked in the free run.

    • cites [9] 2007, A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?, Arch Gen Psychiatry source

      Not checked in the free run.

    • cites [12] 2012, Mortality in first-contact psychosis patients in the U.K.: a cohort study, Psychol Med source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Study design and conductown data

    SMRs were calculated based on observed deaths in the cohort and expected deaths for each study center by age band and sex derived from ONS mortality rates and population estimates.

    “Standardized mortality ratios (SMRs) and 95% confidence intervals (CIs) for all, natural, and unnatural causes of death were calculated based on the observed number of deaths in the cohort and the expected number of deaths for each study center by age band and sex derived from ONS all-, natural-, and unnatural-cause mortality rates (in the population at risk) and population estimates.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    Poisson regression modeling controlled for potential confounders based on change in magnitude of effect and association with outcome.

    “Poisson regression modeling was conducted to quantify the effect of these characteristics on risk of all-, natural-, and unnatural-cause mortality in people with first-episode psychosis while controlling for potential confounders based on (a) the level of change in the magnitude of effect of interest and (b) whether potential confounders were associated with the outcome”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    The mortality gap in people with schizophrenia and other psychoses remains high and may be wider for unnatural-cause mortality than reported in earlier studies.

    “Our findings suggest that the mortality gap in people with schizophrenia and other psychoses remains high and may be wider for unnatural-cause mortality than reported in earlier studies”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [9] 2007, A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?, Arch Gen Psychiatry source

      Not checked in the free run.

    • cites [34] 2000, Causes of the excess mortality of schizophrenia, Br J Psychiatry source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    The findings support a role for illicit drug use as both a risk factor and a principal underlying cause of death, and for alcohol use as a principal underlying cause of death.

    “our findings are in support of such a role for illicit drug use as both risk factor and principal underlying cause, as well as for alcohol use as a principal underlying cause”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Mortality is multi-factorial.
  • May combine two claims.

    Interpretationown data

    The burden of excess mortality occurs at younger ages, and people with psychosis die younger than the general population.

    “it suggests that the burden of excess mortality occurs at younger ages and confirms the fact that people with psychosis die younger than the general population.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Findings on the association between exposure to antipsychotic medication and natural-cause mortality remain inconsistent.

    “overall, findings on the association between exposure to antipsychotic medication and natural-cause mortality remain inconsistent.2,48,49”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [2] 2013, Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study, Am J Psychiatry source

      Not checked in the free run.

    • cites [48] 2009, Influence of antipsychotics on mortality in schizophrenia: systematic review, Schizophr Res source

      Not checked in the free run.

    • cites [49] 2006, Schizophrenia, neuroleptic medication and mortality, Br J Psychiatry source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Wahlbeck et al noted that variation in unnatural-cause mortality by sex may result from differences in help-seeking behavior.

    “Wahlbeck et al 10 noted that variation in unnatural-cause mortality by sex may result from differences in help-seeking behavior”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [10] 2011, Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders, Br J Psychiatry source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Interpretationcitation

    A longer time to remission likely involves prolonged periods and higher dose of exposure to antipsychotic medication, which have been posited to increase natural-cause mortality via metabolic mechanisms.

    “a longer time to remission is likely to involve prolonged periods (and higher dose) of exposure to antipsychotic medication, which have been posited to increase natural-cause mortality via metabolic mechanisms.46–48”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [46] 1999, Antipsychotic-induced weight gain: a comprehensive research synthesis, Am J Psychiatry source

      Not checked in the free run.

    • cites [47] 2006, The metabolic effects of antipsychotic medications, Can J Psychiatry source

      Not checked in the free run.

    • cites [48] 2009, Influence of antipsychotics on mortality in schizophrenia: systematic review, Schizophr Res source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Clinical and social factors may have varied over time.

    “clinical and social factors may have varied over time.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductown data

    Mortality as an outcome was rare in this cohort, so confidence intervals were wide and point estimates of rate ratios and SMRs were imprecise.

    “mortality as an outcome, though markedly elevated compared with the local general population, was, from a purely statistical viewpoint, rare in this cohort, such that CIs were wide, introducing imprecision in point estimates of rate ratios and SMRs.”
    Quote in the paperNot a substantial claim
24 of 24
  • The paper relies on this without support.

    Mortality has rarely been investigated in unselected cohorts of first-episode cases of all psychotic disorders.

    “In addition, mortality has rarely been investigated in unselected cohorts of first-episode cases of all psychotic disorders.”
  • The paper relies on this without support.

    Evidence on modifiable clinical and social risk factors which may predict premature death in this population remains very limited.

    “Overall, evidence on modifiable clinical and social risk factors which may predict premature death in this population remains very limited.”
    “but little is known about the clinical and social risk factors which may predict this health inequality and help inform preventative strategies.”
  • The paper relies on this without support.

    The excess mortality in people with psychotic disorders is a major public health concern.

    “The excess mortality in people with psychotic disorders is a major public health concern”
  • The paper relies on this without support.

    Mortality is multi-factorial.

    “mortality is likely to be multi-factorial”
  • The authors state this as an assumption.

    Family involvement may be relevant in reducing unnatural-cause mortality beyond first contact.

    “assuming family involvement may be relevant in reducing unnatural-cause mortality beyond first contact”
  • The paper relies on this without support.

    Many earlier studies included patients with more severe and enduring psychosis rather than first-episode cases.

    “Given many earlier studies have not been cohorts comprising first-episode cases but included patients with more severe and enduring psychosis”
6 of 6

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Natural-cause rate for younger cases is misstated

    Minor

    The text gives 265.6 per 100 000 person-years for younger cases, but Table 1 gives 66.6 for cases aged 16-29 years. The value 265.6 appears in the table's women's row instead.

  • Reported person-years do not produce the all-cause mortality rate

    Minor

    With 39 deaths over 5183.9 person-years, the all-cause rate is 752.3 per 100 000 person-years, not 717.3. The reported rate implies approximately 5437 person-years.

2 of 2

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. World Health Organization, Life Tables for WHO Member States
  2. Oregon Department of Human Services, 2008, Measuring Premature Mortality Among Oregonians
  3. World Health Organization, 1992, The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines
  4. StataCorp, 2011, Stata Statistical Software: Release 12

Cited by

Sorted by citations

Authors
Reininghaus, U., Dutta, R., Dazzan, P., Doody, G. A., Fearon, P., Lappin, J., Heslin, M., Onyejiaka, A., Donoghue, K., Lomas, B., Kirkbride, J. B., Murray, R. M., Croudace, T., Morgan, C., & Jones, P. B.
Affiliations
  • King's College London (GB)
  • University of Nottingham (GB)
  • Trinity College Dublin (IE)
  • University College London (GB)
  • University of York (GB)
  • University of Cambridge (GB)
Corresponding author
Reininghaus, Ulrich
Venue
Schizophrenia Bulletin
Published
2014-09-27
Volume
41
Issue
3
Pages
664-673
ISSN
  • 0586-7614 (ISSN-L)
  • 1745-1701
OpenAlex
W2170663130
Cited by
156
References
50
Citations by year
2026: 2 · 2025: 4 · 2024: 14 · 2023: 8 · 2022: 13 · 2021: 15 · 2020: 20 · 2019: 18 · 2018: 16 · 2017: 15 · 2016: 19 · 2015: 12
FWCI
11.71
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Schizophrenia Bulletin (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by)
  • Discovery Research Portal (University of Dundee) (publishedVersion, cc-by)
  • Repository@Nottingham (University of Nottingham) (publishedVersion, cc-by)
  • UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
  • Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • UCL Discovery (University College London) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion, cc-by)
  • Lirias (KU Leuven) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • Eli Lilly and Company
  • South London and Maudsley NHS Foundation Trust
  • Wellcome Trust (101272, 095844/Z/11/Z, WT087417, HEALTH-F2-2009-241909, 101272/Z/13/Z, 087417, 095844)
  • National Institute for Health and Care Research (RP-PG-0606-1335, NIHR-PDF-201104065, PDF-2011-04-065)
  • Royal Society (101272/ Z/13/Z)
  • Academy of Medical Sciences (AMS-CSF4-Dutta)
  • King's College London
  • European Commission (241909)
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (451‐13‐022)
  • Medical Research Council (G0500817)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
Keywords
excess mortality, first-episode psychosis
MeSH terms
Adolescent, Adult, Aged, Cause of Death, England, Female, Follow-Up Studies, Humans, London, Male, Middle Aged, Psychotic Disorders, Registries, Risk, Schizophrenia, Time Factors, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review